Articoli di riviste sul tema "Appelists"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-23 articoli di riviste per l'attività di ricerca sul tema "Appelists".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Ernst, Wolfgang, e Ghislain Thibault. "Ce que nous appelions « l’histoire des médias » : l’exercice de l’archéologie médiatique". Communiquer. Revue de communication sociale et publique, n. 13 (9 aprile 2015): 91–106. http://dx.doi.org/10.4000/communiquer.1550.
Testo completoSchmidt, Jürgen W. "Stefan Appelius: Die Spionin. Olga Raue. CIA-Agentin im Kalten Krieg". Das Historisch-Politische Buch (HPB): Volume 67, Issue 3 67, n. 3 (1 settembre 2019): 368–69. http://dx.doi.org/10.3790/hpb.67.3.368.
Testo completoSergio, Ivan. "Propaganda fascista en Chile: el caso de Cile e Patagonia (1930), de Mario Appelius". Artcultura 23, n. 43 (24 dicembre 2021): 192–209. http://dx.doi.org/10.14393/artc-v23-n43-2021-64092.
Testo completoBasilone, Linetto. "Through East Asia to the sound of ‘Giovinezza’: Italian travel literature on China, Korea and Japan during the Fascist ventennio". Modern Italy 24, n. 4 (30 settembre 2019): 457–68. http://dx.doi.org/10.1017/mit.2019.52.
Testo completoBrunetti, Mauro M., e Ermanno Quagiotto. "On a new finding of Euciroa arenosa (Rayneval in Appelius, 1871) for the Lower Pliocene of the Mediterranean Basin (Mollusca Bivalvia Euciroidae)". Biodiversity Journal 12, n. 4 (30 dicembre 2021): 993–96. http://dx.doi.org/10.31396/biodiv.jour.2021.12.4.993.996.
Testo completoZarca, Bernard. "Proximités socioprofessionnelles entre germains et entre alliés : une comparaison dans la moyenne durée". Population Vol. 54, n. 1 (1 gennaio 1999): 37–71. http://dx.doi.org/10.3917/popu.p1999.54n1.0071.
Testo completoSingh, Abhay, Sarah Sadek, Mark G. Faber, Jeffrey Baron, James E. Thompson, Amanda Przespolewski, Elizabeth A. Griffiths, Eunice S. Wang e Swapna Thota. "The Ever-Changing Therapeutic Landscape of AML: A Real World Experience of Novel Therapies on Outcomes". Blood 134, Supplement_1 (13 novembre 2019): 5095. http://dx.doi.org/10.1182/blood-2019-132040.
Testo completoVachhani, Pankit, Kyle Wiatrowski, Pragya Srivastava, Lisa King, Jody Manischewitz, Hana Golding, Heather L. Bashaw et al. "Quantification of Humoral Immune Response to Influenza Vaccination in MDS". Blood 134, Supplement_1 (13 novembre 2019): 4756. http://dx.doi.org/10.1182/blood-2019-126176.
Testo completoSrivastava, Pragya, Stephanie Tzetzo, Eduardo Cortes Gomez, Kevin Eng, Prashant K. Singh, Kitty De Jong, Sheila N. J. Sait et al. "Inhibition of LSD1 in Myelodysplastic Syndrome Progenitors Restores Differentiation of CD141Hi Conventional Dendritic Cells". Blood 134, Supplement_1 (13 novembre 2019): 1695. http://dx.doi.org/10.1182/blood-2019-126220.
Testo completoBaron, Jeffrey, Christina L. Lombardi, Han Yu, Amanda Przespolewski, Elizabeth A. Griffiths, James E. Thompson, Swapna Thota e Eunice S. Wang. "Benefits of a Pharmacist Led Oral Chemotherapy Monitoring Program for Patients with Chronic Myeloid Malignancies: A Patient Reported Outcome (PRO) Study". Blood 134, Supplement_1 (13 novembre 2019): 3501. http://dx.doi.org/10.1182/blood-2019-131629.
Testo completoThota, Swapna, Abhay Singh, Sarah Sadek, Mark G. Faber, Jeffrey Baron, Amro Elshoury, James E. Thompson, Amanda Przespolewski, Elizabeth A. Griffiths e Eunice S. Wang. "Outcomes of AML Patients Treated with Gemtuzumab-Ozogamicin Based Therapies: A Cue to Optimal Chemotherapy Backbone". Blood 134, Supplement_1 (13 novembre 2019): 2645. http://dx.doi.org/10.1182/blood-2019-131633.
Testo completoWang, Youjin, Weiyin Zhou, Lisa J. McReynolds, Elizabeth A. Griffiths, Swapna Thota, Mitchell Machiela, Stephen J. Chanock et al. "De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Transplant Blood Samples". Blood 134, Supplement_1 (13 novembre 2019): 1430. http://dx.doi.org/10.1182/blood-2019-129110.
Testo completoPandey, Manu, Mahesh Swaminathan, Elizabeth A. Griffiths, James E. Thompson, Amanda Przespolewski, Swapna Thota, Jeffrey Baron, Tara L. Cronin e Eunice S. Wang. "Outcomes of Venetoclax-Based Regimens Compared with Hypomethylating Agents (HMA) Alone or 7+3 in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia (AML): A Single Center Retrospective Analysis". Blood 134, Supplement_1 (13 novembre 2019): 3866. http://dx.doi.org/10.1182/blood-2019-132123.
Testo completoPrzespolewski, Amanda, Craig W. Freyer, Wenyan Ji, Tara L. Cronin, Swapna Thota, Elizabeth A. Griffiths, James E. Thompson et al. "Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor ± Mitoxantrone (CLAG ± M) Is Highly Effective Therapy for Secondary and Relapsed/Refractory Acute Myeloid Leukemia". Blood 134, Supplement_1 (13 novembre 2019): 1361. http://dx.doi.org/10.1182/blood-2019-130582.
Testo completoNavada, Shyamala C., Guillermo Garcia-Manero, Ehab L. Atallah, M. Nabeel Rajeh, Jamile M. Shammo, Elizabeth A. Griffiths, Samer K. Khaled et al. "Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)". Blood 134, Supplement_1 (13 novembre 2019): 566. http://dx.doi.org/10.1182/blood-2019-131676.
Testo completoWang, Eunice S., Elizabeth A. Griffiths, Roland B. Walter, Martin S. Tallman, Aaron D. Goldberg, Boo Messahel e Richard M. Stone. "Tolerability and Efficacy of Crenolanib and Cytarabine/Anthracycline Chemotherapy in Older Patients (Aged 61 to 75) with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)". Blood 134, Supplement_1 (13 novembre 2019): 3829. http://dx.doi.org/10.1182/blood-2019-130536.
Testo completoIssa, Jean-Pierre, Marco Gobbi, Patricia L. Kropf, Pierre Fenaux, Gail J. Roboz, Jiri Mayer, Jürgen Krauter et al. "Progression Free Survival (PFS), and Event Free Survival (EFS) from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC): ASTRAL-1 Study". Blood 134, Supplement_1 (13 novembre 2019): 4235. http://dx.doi.org/10.1182/blood-2019-129614.
Testo completoGriffiths, Elizabeth A., Hagop M. Kantarjian, Casey L. O'Connell, Karen W. L. Yee, Wendy Stock, Naval G. Daver, Elias Jabbour et al. "Durable Remission and Long-Term Survival in Relapsed/Refractory (r/r) AML Patients Treated with Guadecitabine, Median Survival Not Reached for Responders after Long Term Follow up from Phase 2 Study of 103 Patients". Blood 134, Supplement_1 (13 novembre 2019): 1319. http://dx.doi.org/10.1182/blood-2019-131394.
Testo completoRoboz, Gail J., Hartmut Döhner, Marco Gobbi, Patricia L. Kropf, Jiri Mayer, Jürgen Krauter, Tadeusz Robak et al. "Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Naïve (TN) AML Unfit for Intensive Chemotherapy (IC) ASTRAL-1 Study: Analysis By Number of Cycles". Blood 134, Supplement_1 (13 novembre 2019): 2591. http://dx.doi.org/10.1182/blood-2019-127253.
Testo completoGarcia-Manero, Guillermo, James McCloskey, Elizabeth A. Griffiths, Karen W. L. Yee, Amer M. Zeidan, Aref Al-Kali, Kim-Hien Dao et al. "Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ASTX727 (cedazuridine/decitabine) Compared to IV Decitabine". Blood 134, Supplement_1 (13 novembre 2019): 846. http://dx.doi.org/10.1182/blood-2019-122980.
Testo completoYee, Karen W. L., Gail J. Roboz, Casey L. O'Connell, Elizabeth A. Griffiths, Raoul Tibes, Katherine J. Walsh, Wendy Stock et al. "Landmark Response and Survival Analyses from 206 AML Patients Treated with Guadecitabine in a Phase 2 Study Demonstrate the Importance of Adequate Treatment Duration to Maximize Response and Survival Benefit. Survival Benefit Not Restricted to Patients with Objective Response". Blood 134, Supplement_1 (13 novembre 2019): 3846. http://dx.doi.org/10.1182/blood-2019-129845.
Testo completoWang, Michael, Jacqueline C. Barrientos, Richard R. Furman, Matthew Mei, Paul M. Barr, Michael Y. Choi, Sven de Vos et al. "VLS-101, a ROR1-Targeting Antibody-Drug Conjugate, Demonstrates a Predictable Safety Profile and Clinical Efficacy in Patients with Heavily Pretreated Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma". Blood 136, Supplement 1 (5 novembre 2020): 13–14. http://dx.doi.org/10.1182/blood-2020-136373.
Testo completoSavona, Michael R., Hagop M. Kantarjian, Gail J. Roboz, Casey L. O'Connell, Katherine J. Walsh, Raoul Tibes, Karen W. L. Yee et al. "Landmark Response and Survival Analyses from 102 MDS and CMML Patients Treated with Guadecitabine in a Phase 2 Study Showing That Maximum Response and Survival Is Best Achieved with Adequate Treatment Duration". Blood 134, Supplement_1 (13 novembre 2019): 2957. http://dx.doi.org/10.1182/blood-2019-129962.
Testo completo